title: Inhibitor-induced conformational stabilization and structural alteration of a mip-like peptidyl prolyl cis-trans isomerase and its C-terminal domain.
abstract: FKBP22, an Escherichia coli-encoded PPIase (peptidyl-prolyl cis-trans isomerase) enzyme, shares substantial identity with the Mip-like pathogenic factors, caries two domains, exists as a dimer in solution and binds some immunosuppressive drugs (such as FK506 and rapamycin) using its C-terminal domain (CTD). To understand the effects of these drugs on the structure and stability of the Mip-like proteins, rFKBP22 (a chimeric FKBP22) and CTD+ (a CTD variant) have been studied in the presence and absence of rapamycin using different probes. We demonstrated that rapamycin binding causes minor structural alterations of rFKBP22 and CTD+. Both the proteins (equilibrated with rapamycin) were unfolded via the formation of intermediates in the presence of urea. Further study revealed that thermal unfolding of both rFKBP22 and rapamycin-saturated rFKBP22 occurred by a three-state mechanism with the synthesis of intermediates. Intermediate from the rapamycin-equilibrated rFKBP22 was formed at a comparatively higher temperature. All intermediates carried substantial extents of secondary and tertiary structures. Intermediate resulted from the thermal unfolding of rFKBP22 existed as the dimers in solution, carried an increased extent of hydrophobic surface and possessed relatively higher rapamycin binding activity. Despite the formation of intermediates, both the thermal and urea-induced unfolding reactions were reversible in nature. Unfolding studies also indicated the considerable stabilization of both proteins by rapamycin binding. The data suggest that rFKBP22 or CTD+ could be exploited to screen the rapamycin-like inhibitors in the future.
authors: Department of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
authors: Soumitra
authors: S
authors: Polley
authors: Department of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
authors: Biswanath
authors: B
authors: Jana
authors: Dr. B.C. Guha Centre for Genetic Engineering & Biotechnology, University of Calcutta, Kolkata, West Bengal, India.
authors: Gopal
authors: G
authors: Chakrabarti
authors: Department of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
authors: Subrata
authors: S
authors: Sau
mesh_terms: D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D019696:Peptidylprolyl Isomerase / Q000037:antagonists & inhibitors* / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation / Q000187:drug effects*; D054730:Protein Interaction Domains and Motifs / Q000187:drug effects*; D058767:Protein Unfolding / Q000187:drug effects; D059748:Proteolysis; D020123:Sirolimus / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D022021:Tacrolimus Binding Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry; D013816:Thermodynamics; D013820:Thermolysin / Q000378:metabolism; D014508:Urea / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D014508:Urea; D013820:Thermolysin; C403422:FKBP22; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D020123:Sirolimus